Fidelity Investments
CALA

Fidelity Investments’s Calithera Biosciences, Inc CALA Stock Holding History

Fidelity Investments’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-285
Closed -$20K – 4428
2020
Q3 		$20K Sell
285
-810
-74% -$70.7K ﹤0.01% 3059
2020
Q2 		$116K Buy
+1,095
New +$130K ﹤0.01% 2703
2019
Q1 		– Sell
-10
Closed -$1K – 4373
2018
Q4 		$1K Sell
10
-10
-50% -$986 ﹤0.01% 3457
2018
Q3 		$2K Buy
+20
New +$1.9K ﹤0.01% 3419
2018
Q2 		– Sell
-34,036
Closed -$4.29M – 2747
2018
Q1 		$4.29M Hold
34,036
– – ﹤0.01% 2209
2017
Q4 		$5.68M Sell
34,036
-72,800
-68% -$18.6M ﹤0.01% 2132
2017
Q3 		$33.7M Sell
106,836
-29,019
-21% -$9.15M ﹤0.01% 1496
2017
Q2 		$40.3M Buy
135,855
+62,745
+86% +$16.8M 0.01% 1379
2017
Q1 		$16.9M Buy
73,110
+53,780
+278% +$9.29M ﹤0.01% 1757
2016
Q4 		$1.26M Buy
19,330
+1,230
+7% +$76.8K ﹤0.01% 2442
2016
Q3 		$1.18M Sell
18,100
-82,014
-82% -$5.29M ﹤0.01% 2435
2016
Q2 		$7.43M Sell
100,114
-31,359
-24% -$3.14M ﹤0.01% 2082
2016
Q1 		$14.9M Sell
131,473
-3,125
-2% -$354K ﹤0.01% 1801
2015
Q4 		$20.6M Hold
134,598
– – ﹤0.01% 1675
2015
Q3 		$14.6M Hold
134,598
– – ﹤0.01% 1783
2015
Q2 		$19.2M Buy
134,598
+27,963
+26% +$6.48M ﹤0.01% 1746
2015
Q1 		$35M Sell
106,635
-110
-0.1% -$39.1K ﹤0.01% 1497
2014
Q4 		$43.1M Buy
+106,745
New +$27.9M 0.01% 1402

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Fidelity Investments's CALA Position: Q4 2020 in Review

Fidelity Investments sold out of Calithera Biosciences, Inc (CALA) in Q4 2020, closing a stake of 285 shares — an estimated $20K sold.

Fidelity Investments first reported a position in CALA in Q4 2014 and held it in 18 quarters. The position peaked at $43.1M in Q4 2014. 105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • Fidelity Investments reported no remaining Calithera Biosciences, Inc position as of Q4 2020 after selling out during the quarter.
  • Fidelity Investments sold 285 Calithera Biosciences, Inc shares in Q4 2020, an estimated $20K.
  • Fidelity Investments first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 18 quarters.
  • Fidelity Investments's Calithera Biosciences, Inc position peaked at $43.1M in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on Fidelity Investments's 13F filing for Q4 2020, filed 8 Feb 2021.